Patents by Inventor Jose Engelmayer

Jose Engelmayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8247373
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 21, 2012
    Assignee: Agennix Incorporated
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Publication number: 20120010150
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Application
    Filed: September 8, 2011
    Publication date: January 12, 2012
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Patent number: 8030272
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: October 4, 2011
    Assignee: Agennix Incorporated
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Publication number: 20090253627
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Application
    Filed: March 12, 2009
    Publication date: October 8, 2009
    Applicant: AGENNIX INCORPORATED
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Patent number: 7524814
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Grant
    Filed: September 16, 2003
    Date of Patent: April 28, 2009
    Assignee: Agennix, Inc.
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Patent number: 7420033
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: September 2, 2008
    Assignee: Agennix, Inc.
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Patent number: 7262279
    Abstract: The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbA1c).
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: August 28, 2007
    Assignee: Agennix, Inc.
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Publication number: 20070142292
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Application
    Filed: February 22, 2007
    Publication date: June 21, 2007
    Applicant: AGENNIX INCORPORATED
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Patent number: 7183381
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Grant
    Filed: October 26, 2005
    Date of Patent: February 27, 2007
    Assignee: Agennix, Inc.
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Publication number: 20060205634
    Abstract: The present invention relates to methods of using lactoferrin (LF) to reduce circulating levels of cholesterol and vascular inflammation, in order to treat, prevent or reduce the incidence of atherosclerosis and cardiovascular disease.
    Type: Application
    Filed: April 10, 2006
    Publication date: September 14, 2006
    Inventors: Atul Varadhachary, Peter Glynn, Yenyun Wang, Jose Engelmayer
  • Publication number: 20060189513
    Abstract: The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbA1c).
    Type: Application
    Filed: April 11, 2006
    Publication date: August 24, 2006
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Publication number: 20060094082
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Application
    Filed: October 26, 2005
    Publication date: May 4, 2006
    Applicant: AGENNIX INCORPORATED
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Patent number: 7034126
    Abstract: The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbAlc).
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: April 25, 2006
    Assignee: Agennix, Inc.
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Patent number: 7026295
    Abstract: The present invention relates to methods of using lactoferrin (LF) to reduce circulating levels of cholesterol and vascular inflammation, in order to treat, prevent or reduce the incidence of atherosclerosis and cardiovascular disease.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: April 11, 2006
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Peter Glynn, Yenyun Wang, Jose Engelmayer
  • Publication number: 20050004006
    Abstract: The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbAlc).
    Type: Application
    Filed: May 13, 2004
    Publication date: January 6, 2005
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Publication number: 20040152623
    Abstract: The present invention relates to methods of using lactoferrin (LF) to reduce circulating levels of cholesterol and vascular inflammation, in order to treat, prevent or reduce the incidence of atherosclerosis and cardiovascular disease.
    Type: Application
    Filed: December 4, 2003
    Publication date: August 5, 2004
    Inventors: Atul Varadhachary, Peter Glynn, Yenyun Wang, Jose Engelmayer
  • Publication number: 20040142037
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Application
    Filed: September 16, 2003
    Publication date: July 22, 2004
    Inventors: Jose Engelmayer, Atul Varadhachary